dexpanthenol: Clinical Trials

6 trials of dexpanthenol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Terminated 1

Follow dexpanthenol: new trials by email Literature Review of dexpanthenol trials Research Report on dexpanthenol

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Pediatric Drugs in Nasal Congestion
Naridrin, Afrin - Nasal Congestion
Phase 3CompletedEMS2922018-01-162019-10-16
Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy
CO2-laser, Vaseline, Bepanthen - Photodamaged Skin
Phase 3CompletedRWTH Aachen University372017-03-012018-05-30
Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment
Pedyphar Ointment, Panthenol - Diabetic Foot Ulcer
Phase 3CompletedEuropean Egyptian Pharmaceutical Industries802013-04-012015-03-05
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
naphazoline hydrocloride, Naphazoline hydrocloride + Pheniramine Maleate + Panthenol - Flu, Cold
Phase 3CompletedEMS1322013-01-012019-01-25
Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers
Royal Jelly and Panthenol (PedyPhar® Ointment), Panthenol Ointment - Diabetic Foot Ulcer
Phase 3TerminatedEuropean Egyptian Pharmaceutical Industries472011-07-012015-02-20
Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)
dexpanthenol 5% cream, Cetomacrogol cream - Cancer, Skin Rash
Phase 3CompletedImpaqtt Foundation1602010-09-012017-11-13

Conditions studied

Diabetic Foot (2)  ·  Common Cold (1)  ·  Exanthema (1)  ·  Foot Ulcer (1)  ·  Influenza, Human (1)  ·  Nasal Obstruction (1)  ·  Neoplasms (1)  ·  Ulcer (1)

Sponsors

EMS (2)  ·  European Egyptian Pharmaceutical Industries (2)  ·  Impaqtt Foundation (1)  ·  RWTH Aachen University (1)

Countries

Egypt (2)  ·  Brazil (1)  ·  Germany (1)  ·  Netherlands (1)

Top investigators

Christine Boers-Doets, MSc (1)  ·  Hesham M Abdel Samad, PhD (1)  ·  Jens M. Baron, Prof. Dr. med. (1)  ·  Johan Nortier, PhD (1)  ·  Mario Lacouture, MD (1)  ·  Samir H Assaad, PhD (1)  ·  Samir H. Asaad, Prof. (1)

Results publications

PMID 23417565, PMID 26111953, PMID 31564933, PMID 41351479